Eversept Partners »

Chemed Corp Com Stk shares owned by Eversept Partners

Quarter-by-quarter ownership of Chemed Corp Com Stk (CHE) shares owned by Eversept Partners from 13F filings

Historical chart of Eversept Partners investment in Chemed Corp Com Stk

Tip: Access up to 7 years of quarterly data

All positions including Chemed Corp Com Stk held by Eversept Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemed Corp Com Stk by Eversept Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 31k 377.74

More positions owned by Eversept Partners

United Therapeutics Corporation (UTHR)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
GSK Sponsored Adr (GSK)
Vera Therapeutics Cl A (VERA)
Natera (NTRA)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Brookdale Senior Living (BKD)
Ionis Pharmaceuticals (IONS)
Qiagen Nv Ord Shares (QGEN)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Hca Holdings (HCA)

View all positions for Eversept Partners

Top funds holding Chemed Corp Com Stk

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
AQR Capital Management
Geode Capital Management
Acadian Asset Management
Two Sigma Investments
TD Asset Management
Epoch Investment Partners
Dimensional Fund Advisors
Neuberger Berman Group
River Road Asset Management
First Trust Advisors
Morgan Stanley

View all funds holding Chemed Corp Com Stk